Towards Post-Genomic Oncology: Embracing Cancer Complexity via Artificial Intelligence, Multi-Targeted Therapeutics, Drug Repurposing, and Innovative Study Designs
International Journal of Molecular Sciences · 10.08.2025 · 26 (16) · 7723
DOI: 10.3390/ijms26167723 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.08.2025. Verfasst von Annabella Di Mauro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Repositioning, Neoplasms, Molecular Targeted Therapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recent advances in precision oncology have led to significant breakthroughs through the targeting of defined oncogenic drivers. However, the clinical efficacy of single-target therapies is increasingly constrained by the intrinsic complexity and adaptability of cancer. Solid tumors frequently arise from multifactorial oncogenic processes and adapt via diverse resistance mechanisms, ultimately limiting the durability of monotherapies. This review advocates for a paradigm shift toward multi-targeted, AI-enhanced strategies that harness high-throughput multi-omic data to inform the rational design of combination therapies. By leveraging artificial intelligence for drug discovery and repurposing, response prediction, and clinical trial optimization, the field of oncology is poised to transcend reductionist approaches and more fully address the biological intricacy of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, 80131 Naples, Italy.
- Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
- Department of Genetics, AMES, Centro Polidiagnostico Strumentale srl, Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
ORCID-Profile: Annabella Di Mauro, Massimiliano Berretta, Gerardo Ferrara, Giovanni Savarese, Alessandro Ottaiano
Zitieren
APA
Di Mauro, A., Berretta, M., Santorsola, M., Ferrara, G., Picone, C., Savarese, G., & Ottaiano, A. (2025). Towards Post-Genomic Oncology: Embracing Cancer Complexity via Artificial Intelligence, Multi-Targeted Therapeutics, Drug Repurposing, and Innovative Study Designs. International Journal of Molecular Sciences, 26(16), 7723. https://doi.org/10.3390/ijms26167723
Vancouver
Di Mauro A, Berretta M, Santorsola M, Ferrara G, Picone C, Savarese G, et al. Towards Post-Genomic Oncology: Embracing Cancer Complexity via Artificial Intelligence, Multi-Targeted Therapeutics, Drug Repurposing, and Innovative Study Designs. International Journal of Molecular Sciences. 2025;26(16):7723. doi:10.3390/ijms26167723
BibTeX
@article{DiMauro2025,
author = {Di Mauro, Annabella and Berretta, Massimiliano and Santorsola, Mariachiara and Ferrara, Gerardo and Picone, Carmine and Savarese, Giovanni and Ottaiano, Alessandro},
title = {Towards Post-Genomic Oncology: Embracing Cancer Complexity via Artificial Intelligence, Multi-Targeted Therapeutics, Drug Repurposing, and Innovative Study Designs},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {16},
pages = {7723},
doi = {10.3390/ijms26167723}
}
EUVIMED